A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
888 patients around the world
Available in Mexico, United States
Eli Lilly and Company
6Research sites
888Patients around the world
This study is for people with
Diabetes
Diabetes mellitus type 2
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Cryptex Investigación Clínica
Av. Insurgentes Sur 101, México DF
IDON S.C Instituto de Diabetes, Obesidad y Nutricion